PAREXEL FOR GLOBAL TRIALS
We’ve been a trusted partner in China for 25 years — earning recognition from Healthcare Executive Magazine as one of China’s top life sciences companies as we help global customers speed their medicines to patients.
Why Choose Parexel
Global expertise, Local insight: China and beyond,
We seamlessly blend our extensive global network with deep local knowledge of China's unique market landscape. Our expertise ensures your clinical trials are executed with precision and efficiency, whether in China alone or as part of a global study.
Break into the China -- the world’s second largest healthcare market -- with our advisory services
For companies of all sizes looking to address unmet needs in China, our experts are ready to help. We simplify the complex regulatory, development, market access, and commercial landscape in China. Our team includes former NMPA, FDA, and EMEA regulators, development specialists, market access experts, and commercial strategy leaders
Tap into deep experience across multiple specializations
We’re equipped with the knowledge and experience to deliver trials quickly and efficiently. In the past five years, we’ve conducted 500+ projects in China (as of July 8, 2024) and have specialized expertise in oncology/hematology, CNS, immunology, anti-infective, metabolic/endocrinology, and cardiology.
Execute better trials by leveraging our strategic partnerships
By partnering with various groups, we’re able to innovate, save time, reduce costs, and create more patient-guided trials in China. That includes partnering with specialist groups like:
- One of the largest rare disease patient advocacy Groups (PAG) - Illness Challenge Foundation
- One of the leading cancer hospitals - Cancer Hospital Chinese Academy of Medical Sciences
- Another leading hospital strategic partnership– Ruijing Hospital on real-world research
- As well as real-world data providers, site management organizations, and Phase I unit partners.
